Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network
Alice Garrett(Institute of Cancer Research), Clare Turnbull(Institute of Cancer Research), Helen Hanson(University of Exeter), James Drummond(Cambridge University Hospitals NHS Foundation Trust), Rachel Robinson(Leeds Teaching Hospitals NHS Trust), Emma R. Woodward(Royal Manchester Children's Hospital), Diana Baralle(Princess Anne Hospital), Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Sabrina Talukdar(St George's, University of London), Lucy Side(Unknown), Marc Tischkowitz(University of Cambridge), Gail Norbury(Guy's and St Thomas' NHS Foundation Trust), Alison Callaway(Wessex Regional Genetics Laboratory), George J. Burghel, Andrew J. Wallace(St Mary's Hospital), Miranda Durkie(Sheffield Children's NHS Foundation Trust), Cankut Çubuk(Queen Mary University of London), Mary Alikian(Institute of Cancer Research), Sian Ellard(University of Exeter), D. Gareth Evans(Manchester Academic Health Science Centre), Treena Cranston(Churchill Hospital), Fiona Lalloo(Manchester University NHS Foundation Trust), Ian Berry(Leeds Teaching Hospitals NHS Trust), Diana Eccles(Princess Anne Hospital), Sheila Palmer-Smith(University Hospital of Wales)
Cited by 54
Related Papers
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766
MicroRNA Related Polymorphisms and Breast Cancer Risk
|PLoS ONE|2014|638